Generic name:bevacizumab-awwb (intravenous route) [ be-va-SIZ-yoo-mab-- awwb ]
Drug class:VEGF/VEGFR inhibitors
Medically reviewed by Drugs.com. Last updated on May 13, 2022.
Commonly used brand name(s)
In the U.S.
- Mvasi
Available Dosage Forms:
- Solution
Therapeutic Class: Antineoplastic Agent
Pharmacologic Class: Bevacizumab
Uses for Mvasi
Bevacizumab-awwb injection is given with other medicines to treat patients with metastatic (cancer that has spread) carcinoma of the colon or rectum.
Bevacizumab-awwb injection is also used together with other medicines (eg, carboplatin and paclitaxel) to treat nonsquamous, non-small cell lung cancer (NSCLC) that has spread, come back, or cannot be removed by surgery. It is also used to treat a type of brain tumor called glioblastoma that keeps coming back (recurrent).
Bevacizumab-awwb injection is also used in combination with other medicines (eg, interferon alfa) to treat patients with metastatic kidney cancer. It is also used in combination with other medicines (eg, paclitaxel and cisplatin, or paclitaxel and topotecan) to treat patients with cervical cancer that is continuing, keeps coming back, or has spread to other parts of the body.
Bevacizumab-awwb injection is given with other medicines (eg, carboplatin and paclitaxel), and then used alone to treat stage 3 or 4 epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who had surgery to remove cancer. It is also used in combination with other medicines (eg, paclitaxel, pegylated liposomal doxorubicin, topotecan) to treat platinum-resistant recurrent (cancer that keeps coming back) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who have received 2 previous treatments. This medicine is also given with other medicines (eg, carboplatin and paclitaxel, carboplatin and gemcitabine), and then used alone to treat platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Bevacizumab-awwb is an antineoplastic that helps the body fight cancer. It prev...
